Darier's disease immune and microbiome study
Part of Genetic & congenital, Skin clinical trials.
This study looks at immune markers and gut/skin bacteria in people with Darier's disease. It aims to better understand the condition, which could lead to better treatments in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with moderate to severe Darier's disease
- You are enrolled in French social security (or a similar system)
- You have not used certain treatments recently (like biologics in the past 12 weeks, oral retinoids in the past 6 months, or certain creams/antibiotics in the past 2 weeks)
- You don't have other inflammatory skin diseases like eczema, psoriasis, or lichen planus
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects skin samples and medical information from people with skin conditions caused by their immune system. It helps researchers better understand these diseases and develop new treatments.
This study looks at inflammation in people with vitiligo, psoriasis, atopic dermatitis, or alopecia areata. It aims to understand how these conditions compare, which may lead to better treatments.
This study looks for clues in your skin and blood that could predict how well you'll respond to treatments for conditions like eczema, psoriasis, or lupus. It aims to help doctors choose the best therapy for you.
This study looks at molecular (body-level) signatures in people with chronic inflammatory skin conditions. You may help researchers understand what drives inflammation, while receiving standard (already approved) systemic treatment through routine care.
This study looks at skin samples to better understand inflammatory skin diseases. By studying these samples, researchers hope to find new ways to diagnose and treat these conditions.
This study collects and stores biological samples (biospecimens) from people with skin conditions, people at risk, or healthy volunteers. It helps researchers better understand dermatologic diseases and support future skin research.
Hear when a new Darier Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.